169 results about "Encopresis" patented technology

Described are implantable devices and methods for treating various disorders of the pelvic floor by means of electrical stimulation of the pudendal and sacral nerves, or portions thereof, and optional means for delivering drugs in association therewith. Two or more electrical stimulation regimes are applied on a continuous, alternating, intermittent or other basis to the sacral and pudendal nerves, and optionally one or more drugs are infused, injected or otherwise administered, to appropriate portions of a patient's pelvic floor and pudendal nerve and/or sacral nerve, or portions thereof, in an amount and manner effective to treat a number of disorders, including, but not limited to, urinary and/or fecal voiding dysfunctions such as constipation, incontinence disorders such as urge frequency and urinary retention disorders, sexual dysfunctions such as orgasmic and erectile dysfunction, pelvic pain, prostatitis, prostatalgia and prostatodynia.

Described are implantable devices and methods for treating various disorders of the pelvic floor by means of electrical stimulation of the pudendal or other nerves, and optional means for delivering drugs in association therewith. A method of precisely positioning and implanting a medical electrical lead so as to provide optimal stimulation of the pudendal nerve or a portion thereof is also described. Placement of a stimulation lead next to or on the pudendal nerve may be performed using conventional prior art techniques through gross anatomical positioning, but usually does not result in truly optimal lead placement. One method of the present invention utilizes neurophysiological monitoring to assess the evoked responses of the pudendal nerve, and thereby provide a method for determining the optimal stimulation site. Additionally, one or more electrical stimulation signals are applied, and optionally one or more drugs are infused, injected or otherwise administered, to appropriate portions of a patient's pelvic floor and pudendal nerve or portions thereof in an amount and manner effective to treat a number of disorders, including, but not limited to, urinary and/or fecal voiding dysfunctions such as constipation, incontinence disorders such as urge frequency and urinary retention disorders, sexual dysfunctions such as orgasmic and erectile dysfunction, pelvic pain, prostatitis, prostatalgia and prostatodynia.

A method and system for providing pulsed electrical stimulation to sacral nerves and/or its branches, to provide therapy for urinary/fecal incontinence and other urological disorders. The stimulation system comprising implanted and external components. The pulsed electrical stimulation may be provided using a system which is one from a group comprising: a) an implanted stimulus-receiver with an external stimulator; b) an implanted stimulus-receiver comprising a high value capacitor for storing charge, used in conjunction with an external stimulator; c) a programmer-less implantable pulse generator (IPG) which is operable with an external magnet; d) a programmable implantable pulse generator; e) a combination implantable device comprising both a stimulus-receiver and a programmable IPG; and f) an implantable pulse generator (IPG) comprising a rechargeable battery. In one embodiment, the external components such as the programmer or external stimulator may comprise telemetry means for interrogation or programming of the implanted device from a remote location, over a wide area network.

A therapeutic composition for the treatment of the symptoms of complex regional pain syndrome and the method for preparing the therapeutic agents is disclosed. The therapeutic composition is a stable pharmaceutical composition comprising one or more digestive and/or pancreatic enzymes. The therapeutic composition may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic composition may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using fecal chymotrypsin level as a biomarker for the presence of complex regional pain syndrome, or the likelihood of an individual to develop complex regional pain syndrome is disclosed.

A device (20) for treating a medical condition is provided, and a surgical procedure for implanting the device is disclosed. The device (20) includes a sensor (44), which is adapted to generate a signal responsive to a state of a patient, and at least one electrode (27), which is adapted to be coupled to a pelvic site of the patient. A control unit (22) is adapted to receive the signal, to analyze the signal so as to distinguish between an imminent stress incontinence event and an imminent urge event, and, responsive to analyzing the signal, to apply an electrical waveform to the at least one electrode (27). In various configurations, the device (20) may be used alternatively or additionally to treat fecal incontinence, interstitial cystitis, chronic pelvic pain, or urine retention.

Methods for aiding in the diagnosis of disorders including, but not limited to, PDDs (Pervasive Development Disorders), Dysautonomic disorders, Parkinson's disease and SIDS (Sudden Infant Death Syndrome). In one aspect, a diagnosis method comprises analyzing a stool sample of an individual for the presence of a biological marker (or marker compound) comprising one or more pathogens, which provides an indication of whether the individual has, or can develop, a disorder including, but not limited to, a PDD, Dysautonomia, Parkinsons disease and SIDS. Preferably, the presence of one or more pathogens is determined using a stool immunoassay to determine the presence of antigens in a stool sample, wherein such antigens are associated with one or more pathogens including, but not limited to, Giardia, Cryptosporidium, E. histolytica, C. difficile, Adenovirus, Rotavirus or H. pylori.

In accordance with the present invention, a novel method for improving the stool characteristics, reducing the incidence of diarrhea, and firming the stool of a formula-fed infant of a formula-fed infant has been discovered. The method comprises administering to the infant at least one prebiotic and hydrolyzed pectin.

The invention relates to a disposable absorbent item comprising an absorbent core, lateral leg elastics, a front band, a back elastic, and adhesive tape at the ends of the back elastic, characterised in that a pair of tapes are provided on the external part of the absorbent core, wherein one tape presents an indicator for detecting urine with a pH between 3 and 5, and the other tape presents said indicator in an acid solution for detecting faeces, thereby permitting a differential identification of urine and faeces.

The present invention relates to lotion compositions comprised on a body facing surface of an absorbent article such as a diaper, training pants or adult incontinence product. The lotion composition may be used for reducing the adherence of feces or menses to the human skin. The lotion composition comprises at least two compounds wherein one first compound is liquid at 25° C. and at least one second component which is solid at 25° C. An effective amount of the lotion composition is comprised on a body facing surface of an absorbent article which is intended to be worn by a wearer.

Beverages are provided and administered for producing LIS samples containing cells exfoliated from throughout the gut in sufficient numbers and free of interfering substances such as formed fecal particles for chemical assays and biologic assays for nucleic acid sequence information, and medical diagnosis. A kit is also provided for use by patients without assistance to produce a LIS sample suitable for analysis. A collection kit employs a sequence of the beverages and other ingested substances to produce preserved cells for medical diagnosis, allowing cytologic analysis of the LIS for diagnosis of foregut and hindgut disease. A preliminary cathartic lavage is used to cleanse a patient's digestive tract; at least one stool induced by the preliminary cathartic lavage is collected; and a final cathartic lavage is used to exfoliate and preserve cells from a patient's digestive tract. Time release capsules containing a cathartic medicament can also be used after completing preliminary lavage administration. The kit also allows provides apparatus for collection, sealing, and packing of the collected LIS specimen for analysis.

The equine faeces collection system includes a tubular excrement collection device (2) with a faeces outlet (70) connected to the collection deposit intake (7) and an intake mouth (13) adapted to face the animal's anal area directing the excrement towards the deposit. The collection device (2) has a first collection area (8) with an outlet mouth connected (70) to the collection deposit intake (7), and a second collection area (11) with an intake mouth (13) which is coupled to the first area (8) to move from a rest position to a collection position in which the intake mouth (13) is facing the animal's anal area, where the intake mouth is located over the outlet mouth so that the excrement falls towards the faeces deposit by gravity. In addition, a turbine (9) moved by an electrical motor (10) could be mounted inside the first collection area (8) to help drag the faeces towards the deposit (7).

A feedback controlled artificial sphincter system for anus is composed of an internal unit consisting of wireless communication module, the artificial sphincter which comprises pressure sensing bag, miniature pressure sensor, clamping bag, clamping pressure sensor and liquid bag, the artificial sphincter controller which comprises the regulating circuits for said sensors, miniature hydraulic pump and its driver, and single-chip microprocessor, and the power module, and an external unit consisting of wireless transmitting coil on skin, harmonic oscillator, wireless communication module, and single-chip microprocessor system.

Described are devices and methods for treating various disorders of the pelvic floor by means of electrical stimulation of the pudendal nerves, and means for delivering one or more drugs in association with such electrical stimulation therapies. One or more electrical stimulation signals are applied, and one or more drugs are infused, injected or otherwise administered, to appropriate portions of a patient's pelvic floor and the pudendal nerves or portions thereof in an amount and manner effective to treat a number of disorders, including, but not limited to, urinary voiding dysfunction, fecal voiding dysfunction, constipation, stress incontinence, urge incontinence, urinary retention disorder, sexual dysfunction, orgasmic dysfunction, erectile dysfunction, pelvic pain, prostatitis, prostatalgia and prostatodynia.

A device for treating fecal incontinence in a subject is provided. The device includes a plug configured for positioning mostly within an anal canal of the subject.

The present invention relates to a disposable human waste management devices such as faecal and urine management devices (10) which are provided with adhesives for attachment of the device to the skin. In particular the present invention relates to adhesives (20) which provide secure attachment and are pleasing to the skin upon application, yet cause no discomfort upon removal. In particular the present invention relates to adhesives which provide secure attachment to oily and greasy skins. Preferably the adhesive also provides secure attachment under moist and wet skin conditions and which maintains adhesive peel strength even under exposure to excess water.

The pneumatic system for intussusception treatment, i.e., invagination of a segment of the intestine into an adjacent segment, includes a pressurized gas supply connected to a series of filters, valves, regulators, and sensors connected to a rectal insertion tube to introduce gas at moderate pressure into the intestine of the patient. A computerized control and monitoring subsystem is included. The system preferably includes a heating system to warm the gas as desired. The system also preferably includes an exhaust portion to relieve internal intestinal pressure as required or desired. The exhaust portion of the system preferably includes a filter to absorb undesirable fecal odors that accompany the exhausted gas. At least the rectal insertion tube and the odor filter may be separable from the remainder of the system for convenient disposal. An alarm may be provided to alert the doctor or medical professional of conditions other than normal.

An object of the present invention is to provide a feces treatment agent for colostomy, which on the assumption that characteristics required as a lubricant are shown, can maintain or improve the feces discharge properties from a colostomy pouch, inhibit the development of feces odor, and improve operativity and portability. A feces treatment agent for colostomy, in which an agent A including (1) a granular water-soluble lubricant, (2) a granular water-absorbing gelling agent, (3) sodium bicarbonate, and (4) a component including at least one selected from the group consisting of zinc oxide, limonite and zinc sulfide is contained in a water-soluble base material.

Disclosed is a model human-source flora litter model construction and method for detecting flora in litter intestinal tract. The construction steps contain: (1) prepare healthy people fecal bacteria suspension; (2) paunch to farrowing sow to fetch litters; (3) breed the litters in 24-hour aero-ultra filter positive-pressure draft isolation room; (4) inoculate. The detecting steps contain: (1) extract the fecal microbe genome DNA; (2) analyze ERIC-PCR finger spectrum and community DNA crossing; (3) planting analyze bacillus in HFA litter intestinal tract flora; (4) planting analyze HFA bacteroide in HFA litter tract flora. This invention successfully plant human donator's bacillus and bacteroide in litter model intestinal tract. The finger spectrums comparing shows that the flora finger spectrum in litter model intestinal tract has homologous height with that of the human donator. This invention can be used to study the cross-correlation between intestinal tract flora and its host physiology and immune specificity, also it can be used to evaluate regulation and metabolism effect of functional foods or drugs to intestinal tract flora.

Disclosed is a uroflowmeter attachable to a toilet capable of diagnosing a BPH with high reliability and convenience in a sanitary way without the constraints of a space by checking the urinary flow rate of a patient. The uroflowmeter includes a toilet bowl for temporarily storing feces and urine, a connection tube which has one end introduced into water of the toilet bowl, a pressure measuring unit connected with an opposite end of the connection tube to measure pressure inside the toilet bowl, a signal analyzing unit for analyzing pressure signals from the pressure measuring unit to measure a urinary volume signal and a urinary flow rate signal, a display unit for displaying the urinary flow rate signal measured by the signal analyzing unit, and a wireless transceiver unit for making data communication with the signal analyzing unit in a wireless way.

Presented is an absorbent undergarment with the ability to sense urine, feces and continuously monitor and display the body temperature of the user. The novel integrated undergarment also allows for a contact liquid crystal thermochromic indicator to visually display the user's body temperature. The device may further have the ability to relay the body temperature reading via wireless communication to a remote location, such as a monitoring base, a computer, a Bluetooth receiver, or a handheld wireless device.

A diaper configured for collection of a stool sample for an infant, and an associated method for collection, are disclosed. The diaper may include a backsheet including an effectively urine- and feces-impermeable material; a transverse perineal barrier including an effectively urine- and feces-impermeable material and having a proximal portion overlying the backsheet and sealingly connected to the diaper, and a free distal edge; and a liquid control structure disposed over the backsheet. The diaper may include additional features configured to receive a discharge of urine, isolate fecal material from urine, and facilitate collection of an intact stool sample following elimination.